How much is the Global Sexually Transmitted Disease Market worth?

Global market size is worth USD 171 Bn by 2032.

What was the value of the Sexually Transmitted Disease Market in 2023?

In 2023, the market value stood at USD 95.42 Bn.

Who are the major players operating in the Sexually Transmitted Disease Market?

Bio-Rad Laboratories, Inc., Dickinson and Company, Hologic Inc., Diasorin S.P, F. Hoffmann La Roche AG., Merck And Co. Inc., Gilead Sciences Inc., Inovio Pharmaceuticals Inc., BIOGENIX Inc. Pvt., and Other Key players.

Which region will lead the global Sexually Transmitted Disease Market?

North America is estimated to be the fastest-growing region during the forthcoming years.

Global Sexually Transmitted Disease Market- By Disease Type (Chlamydia, Gonorrhea, Herpes Simplex Virus), By Location (Laboratory Testing and Point of Care Testing), By Devices (Laboratory Devices and Point of Care (POC) devices), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Published date: June 2023
Report ID: 95831
Number of Pages: 248
Format:

Overview
Table of Contents
Major Market Players
Request a Free Sample

- Bio-Rad Laboratories, Inc. Company Profile
- Dickinson and Company
- Hologic Inc.
- Diasorin S.P
- F. Hoffmann La Roche AG.
- Merck And Co. Inc.
- Gilead Sciences Inc.
- Inovio Pharmaceuticals Inc.
- BIOGENIX Inc. Pvt.
- Other Key players.

Related Reports

Enteric Disease Testing Market
Alzheimer’s disease therapeutics Market
Autoimmune Disease Diagnostics Market
Rare Disease Genetic Testing Market
Synchronous Condenser Market
Atopic Dermatitis Drugs Market
Peptic Ulcer Drugs Market

Our Clients

Report ID 95831
Published Date June 2023
Rating
- ★★★★★
  
  ★★★★★
- (58)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible